Sandia Holdings’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
$13.1M Hold
68,771
6.14% 9
2018
Q2
$11.5M Hold
68,771
5.14% 9
2018
Q1
$11.6M Buy
68,771
+17,730
+35% +$2.97M 5.36% 7
2017
Q4
$8.35M Sell
51,041
-42,944
-46% -$7.71M 3.81% 14
2017
Q3
$19.3M Buy
93,985
+17,010
+22% +$3.96M 8.27% 3
2017
Q2
$18.7M Sell
76,975
-8,466
-10% -$1.99M 8.73% 2
2017
Q1
$20.4M Buy
85,441
+13,956
+20% +$3.25M 10.29% 1
2016
Q4
$15M Buy
+71,485
New +$14.8M 8.12% 3

Other funds holding AGN

Sandia Holdings's AGN Position: Q3 2018 in Review

Sandia Holdings held its Allergan plc (AGN) position steady in Q3 2018 at 68,771 shares worth $13.1M. The position accounts for 6.14% of the portfolio, ranked #9.

Sandia Holdings first reported a position in AGN in Q4 2016 and has held it in 8 quarters since. The position peaked at $20.4M in Q1 2017. 1,067 funds tracked by Wall St. Rank hold AGN as of Q3 2018.

  • Sandia Holdings held 68,771 shares of Allergan plc worth $13.1M as of Q3 2018.
  • Sandia Holdings left its Allergan plc share count unchanged in Q3 2018.
  • Allergan plc made up 6.14% of Sandia Holdings's portfolio in Q3 2018, its #9 holding.
  • Sandia Holdings first reported a position in Allergan plc in Q4 2016 and has held it in 8 quarters since.
  • Sandia Holdings's Allergan plc position peaked at $20.4M in Q1 2017.
  • 1,067 funds tracked by Wall St. Rank held Allergan plc as of Q3 2018.

Based on Sandia Holdings's 13F filing for Q3 2018, filed 13 Nov 2018.